sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion]
- RxCUI
- 1494824
- RxNorm name
- sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion]
- Display name
- PLEXION (Topical)
- Full name
- sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion]
- Term type
- SBD
- Status
- Active
- Strength
- 9.8-4.8%
- Dose form
- Lotion
- Route
- Topical
- Updated
- 2026-08-28 14:56:15
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 052014
- Active start
- 052014
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| sulfacetamide sodium | 98 MG / 1 ML | sulfacetamide | sulfacetamide sodium |
| sulfur | 48 MG / 1 ML | sulfur | sulfur |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Lotion | 316983 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| sulfacetamide | 10169 |
| sulfur | 10223 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Plexion (sulfacetamide sodium 9.8 % / sulfur 4.8 % ) Topical Lotion | 1 | NAMES |
| RxNorm Name | sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion] | 1 | NAMES |
| RxNorm Synonym | Plexion (sulfacetamide sodium 9.8 % / sulfur 4.8 % ) Topical Lotion | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1494824 | 1 | CODES |
| MMSL_CODE | BD29600 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 24470-944-02 | 24470-944 | Plexion SULFACETAMIDE SODIUM, SULFUR | Cintex Services, LLC | |
| 44118-703-02 | 44118-703 | Plexion SULFACETAMIDE SODIUM, SULFUR | Eckson Labs LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Plexion | SULFACETAMIDE SODIUM, SULFUR | Cintex Services, LLC | 2f11178a-fe6e-e45a-e063-6294a90aa373 | 2025-02-26 | Warnings, Adverse reactions | 24470-944-02 24470-944 24470094402 1494824 |
| Plexion | SULFACETAMIDE SODIUM, SULFUR | Eckson Labs LLC | db747368-d45d-64e3-e053-2995a90a1fb8 | 2022-03-30 | Warnings, Adverse reactions | 44118-703-02 44118-703 44118070302 1494824 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2f11178a-fe6e-e45a-e063-6294a90aa373 | PLEXION 9.8 % / 4.8 % Topical Lotion [PSN] · sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion] [SBD] · Plexion (sulfacetamide sodium 9.8 % / sulfur 4.8 % ) Topical Lotion [SY] | 3 | 1 | PLEXION ® Lotion (sodium sulfacetamide 9.8%, sulfur 4.8%) | 20250226 |
| db747368-d45d-64e3-e053-2995a90a1fb8 | PLEXION 9.8 % / 4.8 % Topical Lotion [PSN] · sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion] [SBD] · Plexion (sulfacetamide sodium 9.8 % / sulfur 4.8 % ) Topical Lotion [SY] | 3 | 1 | PLEXION ® Lotion (sodium sulfacetamide 9.8%, sulfur 4.8%) | 20220330 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 2f11178a-fe6e-e45a-e063-6294a90aa373 | PLEXION ® Lotion (sodium sulfacetamide 9.8%, sulfur 4.8%) | Cintex Services, LLC | 20250226 |
| f4ad79c1-bdac-40aa-af75-476826c7f009 | Plexion (sodium sulfacetamide 9.8% and sulfur 4.8%) Lotion | Brava Pharmaceuticals, LLC | 20230907 |
| db747368-d45d-64e3-e053-2995a90a1fb8 | PLEXION ® Lotion (sodium sulfacetamide 9.8%, sulfur 4.8%) | Eckson Labs LLC | 20220330 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AF | Antiinfectives for treatment of acne | ATC1-4 | sulfacetamide | |
| ATC | D10AB | Preparations containing sulfur | ATC1-4 | sulfur | |
| ATC | S01AB | Sulfonamides | ATC1-4 | sulfacetamide | |
| FDASPL | D013449 | Sulfonamides | CHEM | has_chemical_structure | sulfacetamide |
| FDASPL | N0000175503 | Sulfonamide Antibacterial | EPC | has_epc | sulfacetamide |
| MEDRT | D013409 | Sulfacetamide | CHEM | has_ingredient | sulfacetamide sodium |
| MEDRT | D013409 | Sulfacetamide | CHEM | has_ingredient | sulfacetamide |
| MEDRT | D013455 | Sulfur | CHEM | has_ingredient | sulfur |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | sulfur |
| MEDRT | D003320 | Corneal Ulcer | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D003320 | Corneal Ulcer | DISEASE | may_treat | sulfacetamide |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | sulfur |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | sulfacetamide |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sulfacetamide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sulfacetamide sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sulfur |
| MEDRT | D004427 | Ear Diseases | DISEASE | may_treat | sulfacetamide |
| MEDRT | D004427 | Ear Diseases | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | sulfacetamide |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | sulfacetamide sodium |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | sulfur |
| MEDRT | D012393 | Rosacea | DISEASE | may_treat | sulfur |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | sulfacetamide |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | sulfacetamide |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | sulfacetamide sodium |
| MEDRT | N0000009946 | Para-Aminobenzoic Acid Inhibitors | MOA | has_moa | sulfacetamide |
| MEDRT | N0000009946 | Para-Aminobenzoic Acid Inhibitors | MOA | has_moa | sulfacetamide sodium |
| MEDRT | N0000008344 | Cellular Growth Phase Arrest | PE | has_pe | sulfacetamide |
| MEDRT | N0000008344 | Cellular Growth Phase Arrest | PE | has_pe | sulfacetamide sodium |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | sulfacetamide |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | sulfacetamide sodium |
| MEDRT | N0000009935 | Decreased Folic Acid Modification | PE | has_pe | sulfacetamide |
| MEDRT | N0000009935 | Decreased Folic Acid Modification | PE | has_pe | sulfacetamide sodium |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 98 MG/ML / 48 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| NAMES | Prescribable Synonym | PLEXION 9.8 % / 4.8 % Topical Lotion |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |